Combating Multiple Myeloma - Professor Andrew Spencer.

Treating Myeloma in 2020 - Professor Andrew SpencerПодробнее

Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment...Подробнее

Blood not bone marrow? Blood testing could improve multiple myeloma diagnosis and therapy: ACBD CAREПодробнее

ACRF Blood Cancer Therapeutics CentreПодробнее

The epigenetics of multiple myeloma and the rationale for HDAC inhibitorsПодробнее

EHA 2016 Andrew Spencer InterviewПодробнее

Clinical Trials in Multiple MyelomaПодробнее

Will it be possible to prevent multiple myeloma?Подробнее

Living With Multiple MyelomaПодробнее

Multiple Myeloma: A Pathway to Better OutcomesПодробнее

Transplantation in modern myeloma therapeuticsПодробнее

Coping with a chronic diseaseПодробнее

Dr. Branagan on Novel Induction Therapies With Transplant in MyelomaПодробнее

Managing Myeloma: Florence's Story (trailer)Подробнее

Real world outcome for high-risk NDMMПодробнее

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and BeyondПодробнее

Sequencing BCMA-targeted therapies in myelomaПодробнее

Multiple MyelomaПодробнее

Promising combination for kappa-restricted RRMM: kappamab, len, dexПодробнее